Target intelligence / Profile preview

Laminin subunit gamma-2 (LAMC2)

Target
LAMC2
Molecular classification
Extracellular matrix glycoprotein, Basement membrane protein, Structural protein
01

Overview

Laminin subunit gamma-2 (LAMC2) is a protein encoded by the LAMC2 gene and is one of three subunits that form laminin 332 (formerly called laminin 5), a key component of anchoring filaments in basement membranes underlying epithelial tissues[1][3][4]. Laminin subunit gamma-2 is essential for cell adhesion, migration, and organization, especially in the skin, where it provides structural resilience and barrier function[3][4][5]. Mutations in LAMC2 cause forms of junctional epidermolysis bullosa, a severe hereditary blistering disorder[3][4]. Overexpression and aberrant localization of laminin gamma-2 have been implicated in tumor invasion and progression across various carcinomas, often localizing at the invasive tumor edge and serving as a prognostic biomarker in oncology[2][7]. Laminin gamma-2 also participates in wound healing, corneal integrity, and dental enamel development[3]. No approved drugs directly target LAMC2, but its key roles in cancer invasion and skin disease highlight its therapeutic and diagnostic relevance[2][7].

Other names
Laminin gamma-2 chainLaminin, gamma 2Kalinin subunit gamma-2Laminin 5 gamma-2 chainLaminin 332 gamma-2 chainLAMCN2LAM5G
02

Biological functions

Cell adhesionCell migrationCell differentiationCellular signalingBasement membrane assembly and anchoringTissue repair (wound healing)
03

Disease associations

Cancer (notably tumor invasion, pancreatic cancer, cholangiocarcinoma)Genetic skin disorders (Junctional epidermolysis bullosa)Other (corneal integrity, tooth enamel development)
04

Safety considerations

Genetic loss/mutation leads to severe skin fragility/blistering (Junctional epidermolysis bullosa)Potential risk of impaired wound healing if targeted
05

Biomarkers

Prognostic biomarker for tumor invasion and progression (notably overexpression at tumor invasive fronts)Diagnostic biomarker for junctional epidermolysis bullosa (genetic testing for LAMC2 mutations)

Beyond the preview

Go deeper on Laminin subunit gamma-2 (LAMC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laminin subunit gamma-2 (LAMC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call